BRIEF-Biocept launches proprietary liquid biopsy test to detect RET fusions in patients with lung cancer

* Biocept launches proprietary liquid biopsy test to detect

RET fusions in patients with lung cancer

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more